Candriam Equities L Biotech.C EUR/ LU1120766388 /
| NAV9/19/2024 | Chg.+3.3200 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 242.0700EUR | +1.39% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 | - | - | - | - | - | -0.99 | 5.05 | -12.19 | -11.06 | 8.94 | 8.18 | -2.47 | - |
| 2016 | -22.94 | -4.98 | -1.15 | 3.16 | 8.63 | -8.23 | 11.81 | -2.00 | 3.03 | -10.54 | 12.73 | -2.27 | -17.18% |
| 2017 | 2.97 | 8.66 | -0.57 | -0.74 | -6.02 | 7.82 | -0.95 | 5.93 | 1.46 | -5.24 | -2.17 | 0.73 | +11.22% |
| 2018 | 2.84 | -2.57 | -2.96 | -1.49 | 8.26 | 0.77 | 4.17 | 4.70 | -1.93 | -11.86 | 4.19 | -9.20 | -6.81% |
| 2019 | 12.70 | 4.36 | 0.82 | -4.77 | -3.93 | 7.06 | 0.91 | - | - | - | - | - | - |
| 2021 | - | - | - | - | - | - | 31.91 | 4.35 | -2.47 | 0.30 | -1.70 | 1.34 | - |
| 2022 | -9.30 | -1.76 | 7.03 | -2.16 | -5.45 | 6.05 | 7.35 | 2.94 | 0.68 | 5.55 | 1.91 | -6.30 | +4.91% |
| 2023 | 1.12 | -3.40 | -2.17 | 0.63 | 2.56 | -0.90 | -1.63 | 1.34 | -2.10 | -5.97 | 2.83 | 12.21 | +3.49% |
| 2024 | 3.19 | 1.72 | 0.15 | -5.32 | 2.24 | 7.00 | 5.30 | -0.55 | 0.08 | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.92% | 16.98% | 17.62% | 20.31% | 21.25% |
| Sharpe ratio | 0.99 | 1.06 | 1.04 | 0.18 | - |
| Best month | +12.21% | +7.00% | +12.21% | +12.21% | - |
| Worst month | -5.32% | -5.32% | -5.97% | -9.30% | - |
| Maximum loss | -9.57% | -7.57% | -9.57% | -19.84% | -19.84% |
| Outperformance | -3.05% | - | -1.13% | +0.44% | - |
All quotes in EUR
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,316.3301 | +24.55% | +8.53% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,440.1799 | +22.11% | +23.00% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,686.8501 | +18.97% | +19.17% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 2,092.7300 | +28.23% | +20.63% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 242.0700 | +21.71% | +22.83% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 388.2500 | +19.70% | +23.51% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 358.2800 | +22.86% | +26.14% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 224.6600 | +22.18% | +6.51% | |
| Candriam Equities L Biotechnolog... | reinvestment | 167.6300 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 677.0600 | +26.32% | +15.35% | |
| Candriam Equities L Biotech.I US... | reinvestment | 6,369.1201 | +27.09% | +16.67% | |
| Candriam Equities L Biotechnolog... | reinvestment | 2,329.1299 | +27.24% | +17.09% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 221.7300 | +24.27% | +8.56% | |
| Candriam Equities L Biotech.R US... | reinvestment | 303.0700 | +27.90% | +19.72% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 231.8600 | +25.32% | +11.26% | |
| Candriam Equities L Biotechnolo... | reinvestment | 951.5300 | +26.78% | +16.77% | |
| Candriam Equities L Biotechnolog... | paying dividend | 868.9200 | +26.74% | +16.65% |
Performance
| YTD | +14.12% | ||
|---|---|---|---|
| 6 Months | +10.27% | ||
| 1 Year | +21.71% | ||
| 3 Years | +22.83% | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | +61.38% | ||
| Year | |||
| 2023 | +3.49% | ||
| 2022 | +4.91% | ||
| 2018 | -6.81% | ||
| 2017 | +11.22% | ||
| 2016 | -17.18% | ||
